As part of a continued growth strategy, Health Monitor is strengthening its digital data analytics capabilities with new product innovations and a major leadership addition. Based on a strong belief that an analytics competency is essential for the development of new products, the company has bolstered its Analytics and Research division with the addition of Steven Blahut, PhD. Dr. Blahut will be joining the company as Vice President, Analytics & Research, reporting directly to the President, Howard Halligan.
Having held leadership positions at IQVIA, Healogix, and Olitzky Whittle, Dr. Blahut brings an exceptional analytics background to Health Monitor. Additionally, he offers significant experience in healthcare statistics across numerous therapeutic areas both from his work at University of Maryland Medical System and as Founding Partner and Head of Advanced Analytics for Health Strategy Partners. In his new role, Dr. Blahut will lead a market research and data analytics team dedicated to identifying ways to develop valuable new products that support the strategic goals of pharmaceutical/OTC brand teams.
“As a targeted marketing platform, we believe in metrics and measurement. It’s how we demonstrate our ability to help grow our clients’ brands.”
Dave Paragamian
CEO, Health Monitor Network
Dave Paragamian, CEO of Health Monitor, commented, “As a targeted marketing platform, we believe in metrics and measurement. It’s how we demonstrate our ability to help grow our clients’ brands. Steve is an incredible addition to our senior leadership team. His data analytics leadership experience will enable Health Monitor to innovate, and drive added measurement of our products in a way never before seen in the industry.”
Dr. Blahut will start in his new role on July 19, 2021.
